Active 0 6 0 6 B-chronic_disease
infection 7 16 7 16 I-chronic_disease
requiring 17 26 17 26 O
intravenous 27 38 27 38 B-treatment
( 39 40 39 40 I-treatment
IV 40 42 40 42 I-treatment
) 42 43 42 43 I-treatment
antibiotics 44 55 44 55 I-treatment
within 56 62 56 62 O
14 63 65 63 65 B-upper_bound
days 66 70 66 70 I-upper_bound
before 71 77 71 77 O
Day 78 81 78 81 O
1 82 83 82 83 O
, 83 84 83 84 O
Cycle 85 90 85 90 O
1 91 92 91 92 O

Adequate 0 8 93 101 O
hematologic 9 20 102 113 O
and 21 24 114 117 O
organ 25 30 118 123 O
function 31 39 124 132 O
within 40 46 133 139 O
28 47 49 140 142 B-upper_bound
days 50 54 143 147 I-upper_bound
before 55 61 148 154 O
the 62 65 155 158 O
first 66 71 159 164 O
study 72 77 165 170 O
treatment 78 87 171 180 O

Administration 0 14 181 195 O
of 15 17 196 198 O
an 18 20 199 201 O
investigational 21 36 202 217 B-treatment
therapeutic 37 48 218 229 I-treatment
agent 49 54 230 235 I-treatment
within 55 61 236 242 O
28 62 64 243 245 B-upper_bound
days 65 69 246 250 I-upper_bound
of 70 72 251 253 O
Cycle 73 78 254 259 O
1 79 80 260 261 O
, 80 81 261 262 O
Day 82 85 263 266 O
1 86 87 267 268 O

Any 0 3 269 272 O
ongoing 4 11 273 280 O
cardiac 12 19 281 288 B-chronic_disease
arrhythmias 20 31 289 300 I-chronic_disease
( 32 33 301 302 O
including 33 42 302 311 O
atrial 43 49 312 318 B-chronic_disease
fibrillation 50 62 319 331 I-chronic_disease
) 62 63 331 332 O
that 64 68 333 337 O
require 69 76 338 345 O
medical 77 84 346 353 B-treatment
therapy 85 92 354 361 I-treatment

Any 0 3 362 365 O
other 4 9 366 371 O
diseases 10 18 372 380 O
, 18 19 380 381 O
cardiovascular 20 34 382 396 B-chronic_disease
, 34 35 396 397 O
pulmonary 36 45 398 407 B-chronic_disease
, 45 46 407 408 O
or 47 49 409 411 O
metabolic 50 59 412 421 B-chronic_disease
dysfunction 60 71 422 433 I-chronic_disease
, 71 72 433 434 O
physical 73 81 435 443 O
examination 82 93 444 455 O
finding 94 101 456 463 O
, 101 102 463 464 O
or 103 105 465 467 O
clinical 106 114 468 476 O
laboratory 115 125 477 487 O
finding 126 133 488 495 O
giving 134 140 496 502 O
reasonable 141 151 503 513 O
suspicion 152 161 514 523 O
of 162 164 524 526 O
a 165 166 527 528 O
disease 167 174 529 536 O
or 175 177 537 539 O
condition 178 187 540 549 O
that 188 192 550 554 O
contraindicates 193 208 555 570 O
the 209 212 571 574 O
use 213 216 575 578 O
of 217 219 579 581 O
an 220 222 582 584 O
investigational 223 238 585 600 O
drug 239 243 601 605 O
or 244 246 606 608 O
that 247 251 609 613 O
may 252 255 614 617 O
affect 256 262 618 624 O
the 263 266 625 628 O
interpretation 267 281 629 643 O
of 282 284 644 646 O
the 285 288 647 650 O
results 289 296 651 658 O
or 297 299 659 661 O
renders 300 307 662 669 O
the 308 311 670 673 O
participants 312 324 674 686 O
at 325 327 687 689 O
high 328 332 690 694 O
risk 333 337 695 699 O
from 338 342 700 704 O
treatment 343 352 705 714 O
complications 353 366 715 728 O

Any 0 3 729 732 O
therapy 4 11 733 740 B-treatment
including 12 21 741 750 O
chemotherapy 22 34 751 763 B-treatment
( 35 36 764 765 O
e.g. 36 40 765 769 O
, 40 41 769 770 O
docetaxel 42 51 771 780 B-treatment
) 51 52 780 781 O
or 53 55 782 784 O
biological 56 66 785 795 B-treatment
therapy 67 74 796 803 I-treatment
( 75 76 804 805 O
e.g. 76 80 805 809 O
, 80 81 809 810 O
vaccine 82 89 811 818 B-treatment
, 89 90 818 819 O
immunotherapy 91 104 820 833 B-treatment
) 104 105 833 834 O
for 106 109 835 838 O
the 110 113 839 842 O
treatment 114 123 843 852 B-treatment
of 124 126 853 855 O
castration 127 137 856 866 B-cancer
- 137 138 866 867 I-cancer
resistant 138 147 867 876 I-cancer
prostate 148 156 877 885 I-cancer
cancer 157 163 886 892 I-cancer

Asymptomatic 0 12 893 905 O
or 13 15 906 908 O
mildly 16 22 909 915 O
symptomatic 23 34 916 927 O
form 35 39 928 932 O
of 40 42 933 935 O
prostate 43 51 936 944 B-cancer
cancer 52 58 945 951 I-cancer

Clinically 0 10 952 962 O
significant 11 22 963 974 O
history 23 30 975 982 O
of 31 33 983 985 O
liver 34 39 986 991 B-chronic_disease
disease 40 47 992 999 I-chronic_disease
consistent 48 58 1000 1010 O
with 59 63 1011 1015 O
Child 64 69 1016 1021 B-clinical_variable
- 69 70 1021 1022 I-clinical_variable
Pugh 70 74 1022 1026 I-clinical_variable
Class 75 80 1027 1032 O
B 81 82 1033 1034 O
or 83 85 1035 1037 O
C 86 87 1038 1039 O

Consent 0 7 1040 1047 O
to 8 10 1048 1050 O
provide 11 18 1051 1058 O
a 19 20 1059 1060 O
formalin 21 29 1061 1069 B-clinical_variable
- 29 30 1069 1070 I-clinical_variable
fixed 30 35 1070 1075 I-clinical_variable
paraffin 36 44 1076 1084 I-clinical_variable
- 44 45 1084 1085 I-clinical_variable
embedded 45 53 1085 1093 I-clinical_variable
( 54 55 1094 1095 I-clinical_variable
FFPE 55 59 1095 1099 I-clinical_variable
) 59 60 1099 1100 I-clinical_variable
tissue 61 67 1101 1107 I-clinical_variable
block 68 73 1108 1113 I-clinical_variable
( 74 75 1114 1115 O
preferred 75 84 1115 1124 O
) 84 85 1124 1125 O
or 86 88 1126 1128 O
a 89 90 1129 1130 O
minimum 91 98 1131 1138 O
of 99 101 1139 1141 O
15 102 104 1142 1144 B-lower_bound
( 105 106 1145 1146 O
20 106 108 1146 1148 O
preferred 109 118 1149 1158 O
) 118 119 1158 1159 O
freshly 120 127 1160 1167 O
cut 128 131 1168 1171 O
unstained 132 141 1172 1181 O
tumor 142 147 1182 1187 B-cancer
slides 148 154 1188 1194 O
from 155 159 1195 1199 O
the 160 163 1200 1203 O
most 164 168 1204 1208 O
recently 169 177 1209 1217 O
collected 178 187 1218 1227 O
, 187 188 1227 1228 O
available 189 198 1229 1238 O
tumor 199 204 1239 1244 O
tissue 205 211 1245 1251 O
accompanied 212 223 1252 1263 O
by 224 226 1264 1266 O
an 227 229 1267 1269 O
associated 230 240 1270 1280 O
pathology 241 250 1281 1290 O
report 251 257 1291 1297 O
( 258 259 1298 1299 O
with 259 263 1299 1303 O
tumor 264 269 1304 1309 O
content 270 277 1310 1317 O
information 278 289 1318 1329 O
, 289 290 1329 1330 O
Gleason 291 298 1331 1338 B-clinical_variable
score 299 304 1339 1344 I-clinical_variable
, 304 305 1344 1345 O
and 306 309 1346 1349 O
disease 310 317 1350 1357 O
staging 318 325 1358 1365 O
) 325 326 1365 1366 O
for 327 330 1367 1370 O
PTEN 331 335 1371 1375 O
IHC 336 339 1376 1379 O
and 340 343 1380 1383 O
NGS 344 347 1384 1387 O
testing 348 355 1388 1395 O
and 356 359 1396 1399 O
for 360 363 1400 1403 O
other 364 369 1404 1409 O
protocol 370 378 1410 1418 O
- 378 379 1418 1419 O
mandated 379 387 1419 1427 O
secondary 388 397 1428 1437 O
and 398 401 1438 1441 O
exploratory 402 413 1442 1453 O
assessments 414 425 1454 1465 O

Eastern 0 7 1466 1473 B-clinical_variable
Collaborative 8 21 1474 1487 I-clinical_variable
Oncology 22 30 1488 1496 I-clinical_variable
Group 31 36 1497 1502 I-clinical_variable
( 37 38 1503 1504 I-clinical_variable
ECOG 38 42 1504 1508 I-clinical_variable
) 42 43 1508 1509 I-clinical_variable
performance 44 55 1510 1521 I-clinical_variable
status 56 62 1522 1528 I-clinical_variable
of 63 65 1529 1531 O
0 66 67 1532 1533 B-lower_bound
or 68 70 1534 1536 O
1 71 72 1537 1538 B-upper_bound
at 73 75 1539 1541 O
screening 76 85 1542 1551 O

Histologically 0 14 1552 1566 O
confirmed 15 24 1567 1576 O
prostate 25 33 1577 1585 B-cancer
adenocarcinoma 34 48 1586 1600 I-cancer
without 49 56 1601 1608 O
neuroendocrine 57 71 1609 1623 B-cancer
differentiation 72 87 1624 1639 I-cancer
or 88 90 1640 1642 I-cancer
small 91 96 1643 1648 I-cancer
- 96 97 1648 1649 I-cancer
cell 97 101 1649 1653 I-cancer
features 102 110 1654 1662 I-cancer

History 0 7 1663 1670 O
of 8 10 1671 1673 O
inflammatory 11 23 1674 1686 B-chronic_disease
bowel 24 29 1687 1692 I-chronic_disease
disease 30 37 1693 1700 I-chronic_disease
( 38 39 1701 1702 O
e.g. 39 43 1702 1706 O
, 43 44 1706 1707 O
Crohn 45 50 1708 1713 B-chronic_disease
disease 51 58 1714 1721 I-chronic_disease
and 59 62 1722 1725 O
ulcerative 63 73 1726 1736 B-chronic_disease
colitis 74 81 1737 1744 I-chronic_disease
) 81 82 1744 1745 O

History 0 7 1746 1753 O
of 8 10 1754 1756 O
ventricular 11 22 1757 1768 B-chronic_disease
dysrhythmias 23 35 1769 1781 I-chronic_disease
or 36 38 1782 1784 O
risk 39 43 1785 1789 O
factors 44 51 1790 1797 O
for 52 55 1798 1801 O
ventricular 56 67 1802 1813 O
dysrhythmias 68 80 1814 1826 O

Immunocompromised 0 17 1827 1844 O
status 18 24 1845 1851 O
because 25 32 1852 1859 O
of 33 35 1860 1862 O
current 36 43 1863 1870 O
known 44 49 1871 1876 O
active 50 56 1877 1883 B-chronic_disease
infection 57 66 1884 1893 I-chronic_disease
with 67 71 1894 1898 O
HIV 72 75 1899 1902 B-chronic_disease
or 76 78 1903 1905 O
because 79 86 1906 1913 O
of 87 89 1914 1916 O
the 90 93 1917 1920 O
use 94 97 1921 1924 O
of 98 100 1925 1927 O
immunosuppressive 101 118 1928 1945 B-treatment
therapies 119 128 1946 1955 I-treatment
for 129 132 1956 1959 O
other 133 138 1960 1965 O
conditions 139 149 1966 1976 O

Known 0 5 1977 1982 O
untreated 6 15 1983 1992 O
or 16 18 1993 1995 O
active 19 25 1996 2002 O
central 26 33 2003 2010 B-cancer
nervous 34 41 2011 2018 I-cancer
system 42 48 2019 2025 I-cancer
( 49 50 2026 2027 I-cancer
CNS 50 53 2027 2030 I-cancer
) 53 54 2030 2031 I-cancer
metastases 55 65 2032 2042 I-cancer
( 66 67 2043 2044 O
progressing 67 78 2044 2055 O
or 79 81 2056 2058 O
requiring 82 91 2059 2068 O
anticonvulsant 92 106 2069 2083 B-treatment
medications 107 118 2084 2095 I-treatment
or 119 121 2096 2098 O
corticosteroids 122 137 2099 2114 B-treatment
for 138 141 2115 2118 O
symptomatic 142 153 2119 2130 O
control 154 161 2131 2138 O
) 161 162 2138 2139 O

Life 0 4 2140 2144 B-clinical_variable
expectancy 5 15 2145 2155 I-clinical_variable
of 16 18 2156 2158 O
at 19 21 2159 2161 O
least 22 27 2162 2167 O
6 28 29 2168 2169 B-lower_bound
months 30 36 2170 2176 I-lower_bound

Major 0 5 2177 2182 O
surgical 6 14 2183 2191 O
procedure 15 24 2192 2201 O
or 25 27 2202 2204 O
significant 28 39 2205 2216 O
traumatic 40 49 2217 2226 B-chronic_disease
injury 50 56 2227 2233 I-chronic_disease
within 57 63 2234 2240 O
28 64 66 2241 2243 B-upper_bound
days 67 71 2244 2248 I-upper_bound
prior 72 77 2249 2254 I-upper_bound
to 78 80 2255 2257 O
Day 81 84 2258 2261 O
1 85 86 2262 2263 O
, 86 87 2263 2264 O
Cycle 88 93 2265 2270 O
1 94 95 2271 2272 O
, 95 96 2272 2273 O
or 97 99 2274 2276 O
anticipation 100 112 2277 2289 O
of 113 115 2290 2292 O
the 116 119 2293 2296 O
need 120 124 2297 2301 O
for 125 128 2302 2305 O
major 129 134 2306 2311 O
surgery 135 142 2312 2319 O
during 143 149 2320 2326 O
study 150 155 2327 2332 O
treatment 156 165 2333 2342 B-treatment

Metastatic 0 10 2343 2353 B-cancer
disease 11 18 2354 2361 I-cancer
documented 19 29 2362 2372 O
prior 30 35 2373 2378 O
to 36 38 2379 2381 O
randomization 39 52 2382 2395 O
by 53 55 2396 2398 O
clear 56 61 2399 2404 O
evidence 62 70 2405 2413 O
of 71 73 2414 2416 O
bone 74 78 2417 2421 O
lesions 79 86 2422 2429 O
on 87 89 2430 2432 O
bone 90 94 2433 2437 O
scan 95 99 2438 2442 O

Need 0 4 2443 2447 O
of 5 7 2448 2450 O
more 8 12 2451 2455 O
than 13 17 2456 2460 O
10 18 20 2461 2463 B-lower_bound
mg 21 23 2464 2466 I-lower_bound
/ 23 24 2466 2467 O
day 24 27 2467 2470 O
of 28 30 2471 2473 O
prednisone 31 41 2474 2484 B-treatment
or 42 44 2485 2487 O
an 45 47 2488 2490 O
equivalent 48 58 2491 2501 O
dose 59 63 2502 2506 O
of 64 66 2507 2509 O
other 67 72 2510 2515 O
anti 73 77 2516 2520 B-treatment
- 77 78 2520 2521 I-treatment
inflammatory 78 90 2521 2533 I-treatment
corticosteroids 91 106 2534 2549 I-treatment
as 107 109 2550 2552 O
a 110 111 2553 2554 O
current 112 119 2555 2562 O
systemic 120 128 2563 2571 B-treatment
corticosteroid 129 143 2572 2586 I-treatment
therapy 144 151 2587 2594 I-treatment
to 152 154 2595 2597 O
treat 155 160 2598 2603 O
a 161 162 2604 2605 O
chronic 163 170 2606 2613 B-chronic_disease
disease 171 178 2614 2621 I-chronic_disease
( 179 180 2622 2623 O
e.g. 180 184 2623 2627 O
, 184 185 2627 2628 O
rheumatic 186 195 2629 2638 B-chronic_disease
disorder 196 204 2639 2647 I-chronic_disease
) 204 205 2647 2648 O

Ongoing 0 7 2649 2656 O
androgen 8 16 2657 2665 B-treatment
deprivation 17 28 2666 2677 I-treatment
with 29 33 2678 2682 I-treatment
gonadotropin 34 46 2683 2695 I-treatment
- 46 47 2695 2696 I-treatment
releasing 47 56 2696 2705 I-treatment
hormone 57 64 2706 2713 I-treatment
( 65 66 2714 2715 I-treatment
GnRH 66 70 2715 2719 I-treatment
) 70 71 2719 2720 I-treatment
analog 72 78 2721 2727 I-treatment
or 79 81 2728 2730 O
bilateral 82 91 2731 2740 B-treatment
orchiectomy 92 103 2741 2752 I-treatment
, 103 104 2752 2753 O
with 105 109 2754 2758 O
serum 110 115 2759 2764 B-clinical_variable
testosterone 116 128 2765 2777 I-clinical_variable
< 129 130 2778 2779 O
= 130 131 2779 2780 O
50 132 134 2781 2783 B-upper_bound
ng 135 137 2784 2786 I-upper_bound
/ 137 138 2786 2787 I-upper_bound
dL 138 140 2787 2789 I-upper_bound
( 141 142 2790 2791 O
< 142 143 2791 2792 O
= 143 144 2792 2793 O
1.7 145 148 2794 2797 B-upper_bound
nmol 149 153 2798 2802 I-upper_bound
/ 153 154 2802 2803 I-upper_bound
L 154 155 2803 2804 I-upper_bound
) 155 156 2804 2805 O
within 157 163 2806 2812 O
28 164 166 2813 2815 B-upper_bound
days 167 171 2816 2820 I-upper_bound
before 172 178 2821 2827 O
randomization 179 192 2828 2841 B-treatment

Pathologic 0 10 2842 2852 O
findings 11 19 2853 2861 O
consistent 20 30 2862 2872 O
with 31 35 2873 2877 O
small 36 41 2878 2883 B-cancer
- 41 42 2883 2884 I-cancer
cell 42 46 2884 2888 I-cancer
or 47 49 2889 2891 I-cancer
neuroendocrine 50 64 2892 2906 I-cancer
carcinoma 65 74 2907 2916 I-cancer
of 75 77 2917 2919 I-cancer
the 78 81 2920 2923 I-cancer
prostate 82 90 2924 2932 I-cancer

Previous 0 8 2933 2941 O
treatment 9 18 2942 2951 B-treatment
with 19 23 2952 2956 O
flutamide 24 33 2957 2966 B-treatment
, 33 34 2966 2967 O
steroidal 35 44 2968 2977 B-treatment
anti 45 49 2978 2982 I-treatment
- 49 50 2982 2983 I-treatment
androgens 50 59 2983 2992 I-treatment
, 59 60 2992 2993 O
androgens 61 70 2994 3003 O
, 70 71 3003 3004 O
estrogens 72 81 3005 3014 B-treatment
, 81 82 3014 3015 O
bicalutamide 83 95 3016 3028 B-treatment
, 95 96 3028 3029 O
nilutamide 97 107 3030 3040 B-treatment
, 107 108 3040 3041 O
or 109 111 3042 3044 O
5 112 113 3045 3046 B-treatment
- 113 114 3046 3047 I-treatment
α 114 115 3047 3048 I-treatment
reductase 116 125 3049 3058 I-treatment
inhibitor 126 135 3059 3068 I-treatment
is 136 138 3069 3071 O
permitted 139 148 3072 3081 O

Prior 0 5 3082 3087 B-treatment
treatment 6 15 3088 3097 I-treatment
with 16 20 3098 3102 I-treatment
5 21 22 3103 3104 I-treatment
- 22 23 3104 3105 I-treatment
alpha 23 28 3105 3110 I-treatment
reductase 29 38 3111 3120 I-treatment
inhibitors 39 49 3121 3131 I-treatment
within 50 56 3132 3138 O
4 57 58 3139 3140 B-upper_bound
weeks 59 64 3141 3146 I-upper_bound
of 65 67 3147 3149 O
Cycle 68 73 3150 3155 O
1 74 75 3156 3157 O
, 75 76 3157 3158 O
Day 77 80 3159 3162 O
1 81 82 3163 3164 O

Prior 0 5 3165 3170 B-treatment
treatment 6 15 3171 3180 I-treatment
with 16 20 3181 3185 I-treatment
abiraterone 21 32 3186 3197 I-treatment
or 33 35 3198 3200 O
other 36 41 3201 3206 O
known 42 47 3207 3212 O
potent 48 54 3213 3219 O
CYP17 55 60 3220 3225 B-treatment
inhibitors 61 71 3226 3236 I-treatment
( 72 73 3237 3238 O
e.g. 73 77 3238 3242 O
, 77 78 3242 3243 O
ketoconazole 79 91 3244 3256 B-treatment
, 91 92 3256 3257 O
orteronel 93 102 3258 3267 B-treatment
) 102 103 3267 3268 O
or 104 106 3269 3271 O
investigational 107 122 3272 3287 O
agents 123 129 3288 3294 O
that 130 134 3295 3299 O
block 135 140 3300 3305 O
androgen 141 149 3306 3314 O
synthesis 150 159 3315 3324 O

Prior 0 5 3325 3330 B-treatment
treatment 6 15 3331 3340 I-treatment
with 16 20 3341 3345 I-treatment
bicalutamide 21 33 3346 3358 I-treatment
( 34 35 3359 3360 I-treatment
Casodex 35 42 3360 3367 I-treatment
® 42 43 3367 3368 I-treatment
) 43 44 3368 3369 I-treatment
or 45 47 3370 3372 O
nilutamide 48 58 3373 3383 B-treatment
( 59 60 3384 3385 I-treatment
Nilandron 60 69 3385 3394 I-treatment
® 69 70 3394 3395 I-treatment
) 70 71 3395 3396 I-treatment
within 72 78 3397 3403 O
6 79 80 3404 3405 B-upper_bound
weeks 81 86 3406 3411 I-upper_bound
of 87 89 3412 3414 O
Cycle 90 95 3415 3420 O
1 96 97 3421 3422 O
, 97 98 3422 3423 O
Day 99 102 3424 3427 O
1 103 104 3428 3429 O

Prior 0 5 3430 3435 B-treatment
treatment 6 15 3436 3445 I-treatment
with 16 20 3446 3450 O
systemic 21 29 3451 3459 B-treatment
radiopharmaceuticals 30 50 3460 3480 I-treatment
( 51 52 3481 3482 O
e.g. 52 56 3482 3486 O
, 56 57 3486 3487 O
radium-223 58 68 3488 3498 B-treatment
and 69 72 3499 3502 O
strontium-89 73 85 3503 3515 B-treatment
) 85 86 3515 3516 O

Progressive 0 11 3517 3528 B-chronic_disease
disease 12 19 3529 3536 I-chronic_disease
before 20 26 3537 3543 O
initiating 27 37 3544 3554 O
study 38 43 3555 3560 O
treatment 44 53 3561 3570 O

Radiopharmaceuticals 0 20 3571 3591 B-treatment
for 21 24 3592 3595 O
the 25 28 3596 3599 O
purpose 29 36 3600 3607 O
of 37 39 3608 3610 O
imaging 40 47 3611 3618 O
are 48 51 3619 3622 O
permitted 52 61 3623 3632 O

Type 0 4 3633 3637 B-chronic_disease
1 5 6 3638 3639 I-chronic_disease
or 7 9 3640 3642 I-chronic_disease
Type 10 14 3643 3647 I-chronic_disease
2 15 16 3648 3649 I-chronic_disease
diabetes 17 25 3650 3658 I-chronic_disease
mellitus 26 34 3659 3667 I-chronic_disease
requiring 35 44 3668 3677 O
insulin 45 52 3678 3685 B-treatment
at 53 55 3686 3688 O
study 56 61 3689 3694 O
entry 62 67 3695 3700 O

Uncontrolled 0 12 3701 3713 O
hypertension 13 25 3714 3726 B-chronic_disease
( 26 27 3727 3728 O
systolic 27 35 3728 3736 B-clinical_variable
blood 36 41 3737 3742 I-clinical_variable
pressure 42 50 3743 3751 I-clinical_variable
≥ 51 52 3752 3753 O
160 53 56 3754 3757 B-lower_bound
mmHg 57 61 3758 3762 I-lower_bound
or 62 64 3763 3765 O
diastolic 65 74 3766 3775 B-clinical_variable
blood 75 80 3776 3781 I-clinical_variable
pressure 81 89 3782 3790 I-clinical_variable
≥ 90 91 3791 3792 O
95 92 94 3793 3795 B-lower_bound
mmHg 95 99 3796 3800 I-lower_bound
) 99 100 3800 3801 O

Use 0 3 3802 3805 O
of 4 6 3806 3808 O
opioid 7 13 3809 3815 B-treatment
medications 14 25 3816 3827 I-treatment
for 26 29 3828 3831 O
cancer 30 36 3832 3838 B-cancer
- 36 37 3838 3839 O
related 37 44 3839 3846 O
pain 45 49 3847 3851 O
, 49 50 3851 3852 O
including 51 60 3853 3862 O
codeine 61 68 3863 3870 B-treatment
and 69 72 3871 3874 O
dextropropoxyphene 73 91 3875 3893 B-treatment
, 91 92 3893 3894 O
currently 93 102 3895 3904 O
or 103 105 3905 3907 O
any 106 109 3908 3911 O
time 110 114 3912 3916 O
within 115 121 3917 3923 O
4 122 123 3924 3925 B-upper_bound
weeks 124 129 3926 3931 I-upper_bound
of 130 132 3932 3934 O
Day 133 136 3935 3938 O
1 137 138 3939 3940 O
, 138 139 3940 3941 O
Cycle 140 145 3942 3947 O
1 146 147 3948 3949 O

active 0 6 3950 3956 O
bowel 7 12 3957 3962 B-chronic_disease
inflammation 13 25 3963 3975 I-chronic_disease
( 26 27 3976 3977 O
e.g. 27 31 3977 3981 O
, 31 32 3981 3982 O
diverticulitis 33 47 3983 3997 B-chronic_disease
) 47 48 3997 3998 O

adequately 0 10 3999 4009 O
treated 11 18 4010 4017 O
non 19 22 4018 4021 B-cancer
- 22 23 4021 4022 I-cancer
melanomatous 23 35 4022 4034 I-cancer
carcinoma 36 45 4035 4044 I-cancer
of 46 48 4045 4047 I-cancer
the 49 52 4048 4051 I-cancer
skin 53 57 4052 4056 I-cancer

adequately 0 10 4057 4067 O
treated 11 18 4068 4075 O
non 19 22 4076 4079 O
- 22 23 4079 4080 O
muscle 23 29 4080 4086 O
- 29 30 4086 4087 O
invasive 30 38 4087 4095 O
urothelial 39 49 4096 4106 B-cancer
carcinoma 50 59 4107 4116 I-cancer
of 60 62 4117 4119 O
the 63 66 4120 4123 O
bladder 67 74 4124 4131 O
( 75 76 4132 4133 O
Tis 76 79 4133 4136 O
, 79 80 4136 4137 O
Ta 81 83 4138 4140 O
, 83 84 4140 4141 O
and 85 88 4142 4145 O
low 89 92 4146 4149 O
grade 93 98 4150 4155 O
T1 99 101 4156 4158 B-cancer
tumors 102 108 4159 4165 I-cancer
) 108 109 4165 4166 O

cirrhosis 0 9 4167 4176 B-chronic_disease

clinically 0 10 4177 4187 O
significant 11 22 4188 4199 O
electrolyte 23 34 4200 4211 O
abnormalities 35 48 4212 4225 O
( 49 50 4226 4227 O
e.g. 50 54 4227 4231 O
, 54 55 4231 4232 O
hypokalemia 56 67 4233 4244 B-chronic_disease
, 67 68 4244 4245 O
hypomagnesemia 69 83 4246 4260 B-chronic_disease
, 83 84 4260 4261 O
hypocalcemia 85 97 4262 4274 B-chronic_disease
) 97 98 4274 4275 O

deemed 0 6 4276 4282 O
by 7 9 4283 4285 O
the 10 13 4286 4289 O
treating 14 22 4290 4298 O
physician 23 32 4299 4308 O
to 33 35 4309 4311 O
have 36 40 4312 4316 O
a 41 42 4317 4318 O
recurrence 43 53 4319 4329 B-clinical_variable
rate 54 58 4330 4334 I-clinical_variable
of 59 61 4335 4337 O
< 62 63 4338 4339 O
5 63 64 4339 4340 B-upper_bound
% 64 65 4340 4341 I-upper_bound
at 66 68 4342 4344 O
5 69 70 4345 4346 B-upper_bound
years 71 76 4347 4352 I-upper_bound

depressed 0 9 4353 4362 O
left 10 14 4363 4367 B-clinical_variable
ventricular 15 26 4368 4379 I-clinical_variable
ejection 27 35 4380 4388 I-clinical_variable
fraction 36 44 4389 4397 I-clinical_variable
( 45 46 4398 4399 O
LVEF 46 50 4399 4403 B-clinical_variable
; 50 51 4403 4404 O
previously 52 62 4405 4415 O
documented 63 73 4416 4426 O
LVEF 74 78 4427 4431 O
< 79 80 4432 4433 O
50 81 83 4434 4436 B-upper_bound
% 83 84 4436 4437 I-upper_bound
without 85 92 4438 4445 O
documentation 93 106 4446 4459 O
of 107 109 4460 4462 O
recovery 110 118 4463 4471 O
) 118 119 4471 4472 O

family 0 6 4473 4479 O
history 7 14 4480 4487 O
of 15 17 4488 4490 O
sudden 18 24 4491 4497 O
unexplained 25 36 4498 4509 O
death 37 42 4510 4515 O
or 43 45 4516 4518 O
long 46 50 4519 4523 B-chronic_disease
QT 51 53 4524 4526 I-chronic_disease
syndrome 54 62 4527 4535 I-chronic_disease

magnetic 0 8 4536 4544 B-treatment
resonance 9 18 4545 4554 I-treatment
imaging 19 26 4555 4562 I-treatment
( 27 28 4563 4564 I-treatment
MRI 28 31 4564 4567 I-treatment
) 31 32 4567 4568 I-treatment
( 33 34 4569 4570 O
at 34 36 4570 4572 O
least 37 42 4573 4578 O
one 43 46 4579 4582 O
target 47 53 4583 4589 O
lesion 54 60 4590 4596 B-chronic_disease
) 60 61 4596 4597 O
according 62 71 4598 4607 O
to 72 74 4608 4610 O
RECIST 75 81 4611 4617 O

measurable 0 10 4618 4628 O
soft 11 15 4629 4633 B-chronic_disease
tissue 16 22 4634 4640 I-chronic_disease
disease 23 30 4641 4648 I-chronic_disease
by 31 33 4649 4651 O
computed 34 42 4652 4660 O
tomography 43 53 4661 4671 O
( 54 55 4672 4673 O
CT 55 57 4673 4675 O
) 57 58 4675 4676 O

myocardial 0 10 4677 4687 B-chronic_disease
infarction 11 21 4688 4698 I-chronic_disease
or 22 24 4699 4701 O
atrial 25 31 4702 4708 B-chronic_disease
thrombotic 32 42 4709 4719 I-chronic_disease
events 43 49 4720 4726 O
within 50 56 4727 4733 O
the 57 60 4734 4737 O
past 61 65 4738 4742 B-upper_bound
6 66 67 4743 4744 I-upper_bound
months 68 74 4745 4751 I-upper_bound

other 0 5 4752 4757 O
malignancies 6 18 4758 4770 B-cancer
where 19 24 4771 4776 O
the 25 28 4777 4780 O
patient 29 36 4781 4788 O
has 37 40 4789 4792 O
undergone 41 50 4793 4802 O
potentially 51 62 4803 4814 O
curative 63 71 4815 4823 B-treatment
therapy 72 79 4824 4831 I-treatment
with 80 84 4832 4836 O
no 85 87 4837 4839 O
evidence 88 96 4840 4848 O
of 97 99 4849 4851 O
disease 100 107 4852 4859 O

severe 0 6 4860 4866 O
unstable 7 15 4867 4875 B-chronic_disease
angina 16 22 4876 4882 I-chronic_disease

structural 0 10 4883 4893 B-chronic_disease
heart 11 16 4894 4899 I-chronic_disease
disease 17 24 4900 4907 I-chronic_disease
( 25 26 4908 4909 O
e.g. 26 30 4909 4913 O
, 30 31 4913 4914 O
severe 32 38 4915 4921 O
left 39 43 4922 4926 B-chronic_disease
ventricular 44 55 4927 4938 I-chronic_disease
systolic 56 64 4939 4947 I-chronic_disease
dysfunction 65 76 4948 4959 I-chronic_disease
, 76 77 4959 4960 O
left 78 82 4961 4965 B-chronic_disease
ventricular 83 94 4966 4977 I-chronic_disease
hypertrophy 95 106 4978 4989 I-chronic_disease
) 106 107 4989 4990 O

untreated 0 9 4991 5000 O
coronary 10 18 5001 5009 B-chronic_disease
heart 19 24 5010 5015 I-chronic_disease
disease 25 32 5016 5023 I-chronic_disease
( 33 34 5024 5025 O
symptomatic 34 45 5025 5036 O
or 46 48 5037 5039 O
with 49 53 5040 5044 O
ischemia 54 62 5045 5053 O
demonstrated 63 75 5054 5066 O
by 76 78 5067 5069 O
diagnostic 79 89 5070 5080 O
testing 90 97 5081 5088 O
) 97 98 5088 5089 O

